Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
prilocaine + sufentanil
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Intrathecal
01
Overview
A combination of prilocaine, a local anesthetic, and sufentanil, a potent opioid analgesic. This combination is used for spinal anesthesia, particularly in ambulatory arthroscopic surgery of the knee. Studies have shown that the combination provides effective anesthesia with faster recovery times compared to some other anesthetic combinations.
02
Targets
MOR (Mu opioid receptor)SCN5A (Sodium channel protein type 5 subunit alpha)
Beyond the preview
Go deeper on prilocaine + sufentanil.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on prilocaine + sufentanil.